Publications by authors named "Xin-Can Liu"
Article Synopsis
- - The novel SARS-CoV-2 is responsible for COVID-19, impacting over 17 million people globally, prompting the need for updated diagnosis and treatment guidelines for clinicians.
- - A working group of experts developed evidence-based recommendations by reviewing literature to address 29 key management questions related to chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19.
- - They issued 34 statements, including 6 strong recommendations, 14 weak recommendations, 3 weak recommendations against, and 11 ungraded consensus statements, covering various aspects such as diagnostic methods and potential treatments.
Clinical trials are the source of evidence. ClinicalTrials.gov is valuable for analyzing current conditions.
View Article and Find Full Text PDFThis study investigated the interaction among valsartan (VAL), TGF-β pathways, and long non-coding RNA (lncRNA) cardiac hypertrophy-related factor (CHRF) in doxorubicin (DOX)-induced heart failure (HF), and explored their roles in DOX-induced HF progression. HF mice models in vivo were constructed by DOX induction. The expression of CHRF and TGF-β1 in hearts was detected, along with cardiac function, caspase-3 activity, and cell apoptosis.
View Article and Find Full Text PDF